🇺🇸
United States · US · US:68382-596_3683dc39-602e-463a-b04a-6d066d2fe94d
diltiazem hydrochloride
In shortageOrange BookUNIISPLATC C05AE03
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerZydus Pharmaceuticals (USA) Inc.
CountryUS (United States)
ATC codeC05AE03
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 5
- ndc116838259601100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-596-01)
- ndc116838259605500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-596-05)
- ndc11683825960630 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-596-06)
- ndc11683825961690 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-596-16)
- ndc11683825967710 BLISTER PACK in 1 CARTON (68382-596-77) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (68382-596-30)
Annotations
UNII (FDA Substance ID)
OLH94387TE
DILTIAZEM HYDROCHLORIDE
RxCUI 203211
Orange Book
A206534
AB3AB3AB3AB3AB3
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Diltiazem Hydrochloride Injection
Raw payload (JSON)
{
"unii": {
"unii": "OLH94387TE",
"rxcui": "203211",
"inchikey": "HDRXZJPWHTXQRI-BHDTVMLSSA-N",
"display_name": "DILTIAZEM HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"f276d9fe-a685-4d99-ad82-d4452ef4ba98": {
"match": "brand_token",
"title": "DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, LLC]",
"spl_version": "10",
"published_date": "2026-06-02"
}
},
"productid": "68382-596_3683dc39-602e-463a-b04a-6d066d2fe94d",
"productndc": "68382-596",
"dosage_form": "CAPSULE, EXTENDED RELEASE",
"orange_book": {
"appl_no": "206534",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB3",
"strength": "120MG",
"product_no": "001",
"approval_date": "Aug 8, 2017"
},
{
"rs": false,
"rld": false,
"te_code": "AB3",
"strength": "180MG",
"product_no": "002",
"approval_date": "Aug 8, 2017"
},
{
"rs": false,
"rld": false,
"te_code": "AB3",
"strength": "240MG",
"product_no": "003",
"approval_date": "Aug 8, 2017"
},
{
"rs": false,
"rld": false,
"te_code": "AB3",
"strength": "300MG",
"product_no": "004",
"approval_date": "Aug 8, 2017"
},
{
"rs": false,
"rld": false,
"te_code": "AB3",
"strength": "360MG",
"product_no": "005",
"approval_date": "Aug 8, 2017"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DILTIAZEM HYDROCHLORIDE",
"shortage_reason": "Diltiazem Hydrochloride Injection",
"shortage_status": "current",
"proprietary_name": "diltiazem hydrochloride",
"active_ingred_unit": "mg/1",
"application_number": "ANDA206534",
"marketing_category": "ANDA",
"nonproprietary_name": "diltiazem hydrochloride",
"start_marketing_date": "20170928",
"active_numerator_strength": "180"
}Related drugs
Other records sharing ATC code C05AE03.
- GBAdizem-SR 120mg capsulesLexon (UK) Ltd
- GBAdizem-SR 120mg capsulesDE Pharmaceuticals
- GBAdizem-SR 120mg capsulesMawdsley-Brooks & Company Ltd
- GBAdizem-SR 120mg capsulesWaymade Healthcare Plc
- GBAdizem-SR 120mg capsulesNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsLexon (UK) Ltd
- GBAdizem-SR 180mg capsulesNapp Pharmaceuticals Ltd
Access this data programmatically
Query diltiazem hydrochloride and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.